Responses
Immunotherapy biomarkers
Original research
Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial
Compose a Response to This Article
Other responses
No responses have been published for this article.